Looking Into C4 Therapeutics’s Return On Capital Employed
According to Benzinga Pro data, during Q1, C4 Therapeutics (NASDAQ:CCCC) posted sales of $3.76 million. Earnings were up…
Expert Ratings for C4 Therapeutics
Within the last quarter, C4 Therapeutics (NASDAQ:CCCC) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
Recap: C4 Therapeutics Q1 Earnings
C4 Therapeutics (NASDAQ:CCCC) reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM. Here’s what…
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 104 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 185 companies achieved new lows for the year.
Where C4 Therapeutics Stands With Analysts
Over the past 3 months, 5 analysts have published their opinion on C4 Therapeutics (NASDAQ:CCCC) stock. These analysts…
